About this FactMed analysis covering adverse side effect reports of MYCOPHENOLATE MOFETIL patients who developed DIZZINESS.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 125 individuals taking MYCOPHENOLATE MOFETIL reported DIZZINESS to the FDA. A total of 16895 MYCOPHENOLATE MOFETIL drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between MYCOPHENOLATE MOFETIL and DIZZINESS. In doing so, we compare MYCOPHENOLATE MOFETIL with other drugs that cause DIZZINESS, to help you evaluate whether or not MYCOPHENOLATE MOFETIL causes DIZZINESS. Likewise, this page shows the most highly-reported side effects of MYCOPHENOLATE MOFETIL, so you can see if DIZZINESS ranks among MYCOPHENOLATE MOFETIL's most well-known side effects.
Summary Statistics
Reports of MYCOPHENOLATE MOFETIL causing DIZZINESS: 125
Reports of any side effect of MYCOPHENOLATE MOFETIL : 16895
Percentage of MYCOPHENOLATE MOFETIL patients where DIZZINESS is a reported side effect: 0.7399%

FDA reports of any drug causing DIZZINESS : 132801
Average percentage for all medicated patients where DIZZINESS is reported as a complication: 0.8323%

Physician opinion on MYCOPHENOLATE MOFETIL as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing MYCOPHENOLATE MOFETIL:
RENAL TRANSPLANT ( 1699 patients )
IMMUNOSUPPRESSION ( 1055 patients )
PROPHYLAXIS AGAINST TRANSPLANT REJECTION ( 714 patients )
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE ( 597 patients )
DRUG USE FOR UNKNOWN INDICATION ( 399 patients )
LIVER TRANSPLANT ( 360 patients )
IMMUNOSUPPRESSANT DRUG THERAPY ( 310 patients )
HEART TRANSPLANT ( 285 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 221 patients )
LUPUS NEPHRITIS ( 173 patients )
SYSTEMIC LUPUS ERYTHEMATOSUS ( 173 patients )
LUNG TRANSPLANT ( 136 patients )
GRAFT VERSUS HOST DISEASE ( 128 patients )
STEM CELL TRANSPLANT ( 104 patients )
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS ( 46 patients )
PROPHYLAXIS ( 45 patients )
TRANSPLANT ( 43 patients )
RENAL AND PANCREAS TRANSPLANT ( 37 patients )
WEGENER'S GRANULOMATOSIS ( 34 patients )
CORD BLOOD TRANSPLANT THERAPY ( 34 patients )
KIDNEY TRANSPLANT REJECTION ( 34 patients )
TRANSPLANT REJECTION ( 33 patients )
LIVER TRANSPLANT REJECTION ( 33 patients )
NEPHROTIC SYNDROME ( 32 patients )
CHRONIC GRAFT VERSUS HOST DISEASE ( 31 patients )
EVANS SYNDROME ( 31 patients )
PEMPHIGUS ( 31 patients )
UVEITIS ( 30 patients )
BONE MARROW TRANSPLANT ( 29 patients )
ACUTE GRAFT VERSUS HOST DISEASE ( 28 patients )
VASCULITIS ( 27 patients )
DRUG EXPOSURE DURING PREGNANCY ( 26 patients )
PYODERMA GANGRENOSUM ( 26 patients )
MYASTHENIA GRAVIS ( 24 patients )
ACUTE MYELOID LEUKAEMIA ( 21 patients )
DERMATITIS ATOPIC ( 19 patients )
AUTOIMMUNE HEPATITIS ( 18 patients )
MULTIPLE MYELOMA ( 12 patients )
AUTOIMMUNE DISORDER ( 11 patients )
FOETAL EXPOSURE DURING PREGNANCY ( 11 patients )
PANCREAS TRANSPLANT ( 11 patients )
ORGAN TRANSPLANT ( 10 patients )
RENAL VASCULITIS ( 10 patients )
BEHCET'S SYNDROME ( 9 patients )
CROHN'S DISEASE ( 9 patients )
DERMATOMYOSITIS ( 9 patients )
RHEUMATOID ARTHRITIS ( 8 patients )
INTERSTITIAL LUNG DISEASE ( 7 patients )
RENAL AND LIVER TRANSPLANT ( 7 patients )
POLYMYOSITIS ( 6 patients )
MYELODYSPLASTIC SYNDROME ( 6 patients )
CHORIORETINOPATHY ( 6 patients )
PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS ( 6 patients )
GLOMERULONEPHRITIS PROLIFERATIVE ( 6 patients )
SCLERODERMA ( 6 patients )
DEMYELINATING POLYNEUROPATHY ( 6 patients )
SJOGREN'S SYNDROME ( 6 patients )
LUNG TRANSPLANT REJECTION ( 5 patients )
RENAL FAILURE ( 5 patients )
CONJUNCTIVITIS ( 5 patients )
HISTOPLASMOSIS ( 5 patients )
MULTIPLE SCLEROSIS ( 5 patients )
ALLOGENIC BONE MARROW TRANSPLANTATION THERAPY ( 5 patients )
IDIOPATHIC THROMBOCYTOPENIC PURPURA ( 5 patients )
SCLERITIS ( 5 patients )
HEART TRANSPLANT REJECTION ( 5 patients )
RENAL AND PANCREAS TRANSPLANT REJECTION ( 5 patients )
GLOMERULONEPHRITIS ( 5 patients )
GLOMERULONEPHRITIS MEMBRANOUS ( 5 patients )
COLITIS ULCERATIVE ( 4 patients )
POSTOPERATIVE CARE ( 4 patients )
HEPATIC NEOPLASM MALIGNANT ( 4 patients )
PROTEINURIA ( 4 patients )
SYSTEMIC SCLEROSIS ( 4 patients )
GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE ( 4 patients )
CRYOGLOBULINAEMIA ( 4 patients )
LICHEN SCLEROSUS ( 4 patients )
PUSTULAR PSORIASIS ( 4 patients )
HEART AND LUNG TRANSPLANT ( 4 patients )
APLASTIC ANAEMIA ( 4 patients )
FOCAL SEGMENTAL GLOMERULOSCLEROSIS ( 4 patients )
KERATITIS HERPETIC ( 4 patients )
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN ( 4 patients )
LICHEN PLANUS ( 4 patients )
IGA NEPHROPATHY ( 4 patients )
APLASIA PURE RED CELL ( 4 patients )
JUVENILE ARTHRITIS ( 3 patients )
KERATOPLASTY ( 3 patients )
POLYCHONDRITIS ( 3 patients )
POLYNEUROPATHY ( 3 patients )
INFLAMMATORY BOWEL DISEASE ( 3 patients )
BLASTOMYCOSIS ( 3 patients )
LUNG DISORDER ( 2 patients )
NEPHROPATHY ( 2 patients )
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME ( 2 patients )
CONNECTIVE TISSUE DISORDER ( 2 patients )
OFF LABEL USE ( 2 patients )
PSORIATIC ARTHROPATHY ( 2 patients )
THROMBOCYTOPENIA ( 2 patients )
ANTI-GLOMERULAR BASEMENT MEMBRANE ANTIBODY ( 2 patients )
URTICARIA CHRONIC ( 2 patients )
ARTHRITIS ( 2 patients )
LUPUS ENCEPHALITIS ( 2 patients )
SMALL INTESTINE TRANSPLANT ( 2 patients )
INTESTINAL TRANSPLANT ( 2 patients )
HEPATITIS C ( 2 patients )
PSORIASIS ( 2 patients )
CUTANEOUS LUPUS ERYTHEMATOSUS ( 2 patients )
MYELOPROLIFERATIVE DISORDER ( 2 patients )
PULMONARY FIBROSIS ( 2 patients )
CARDIOMYOPATHY ( 2 patients )
MYOSITIS ( 2 patients )
HAEMATOLOGICAL MALIGNANCY ( 2 patients )
SKIN GRAFT ( 1 patients )
ARTHRALGIA ( 1 patients )
INFECTION ( 1 patients )
HEPATIC CIRRHOSIS ( 1 patients )
SKIN ULCER ( 1 patients )
ECZEMA ( 1 patients )
NEUROMYELITIS OPTICA ( 1 patients )
NEUROPSYCHIATRIC LUPUS ( 1 patients )
RENAL IMPAIRMENT ( 1 patients )
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE ( 1 patients )
HEPATITIS C POSITIVE ( 1 patients )
MORPHOEA ( 1 patients )
RENAL TUBULAR NECROSIS ( 1 patients )
ACUTE LYMPHOCYTIC LEUKAEMIA ( 1 patients )
CORNEAL TRANSPLANT ( 1 patients )
BLOOD IMMUNOGLOBULIN D INCREASED ( 1 patients )
LEUKOCYTOCLASTIC VASCULITIS ( 1 patients )
GLOMERULONEPHRITIS MINIMAL LESION ( 1 patients )
PEMPHIGOID ( 1 patients )
CYTOMEGALOVIRUS INFECTION ( 1 patients )
ILL-DEFINED DISORDER ( 1 patients )
MYOCLONUS ( 1 patients )
LIVER AND SMALL INTESTINE TRANSPLANT ( 1 patients )
POLYARTERITIS NODOSA ( 1 patients )
SECONDARY IMMUNODEFICIENCY ( 1 patients )
ANTISYNTHETASE SYNDROME ( 1 patients )
IMMUNOMODULATORY THERAPY ( 1 patients )
NECROTISING SCLERITIS ( 1 patients )
RASH ( 1 patients )
ULCERATIVE KERATITIS ( 1 patients )
CHRONIC ALLOGRAFT NEPHROPATHY ( 1 patients )
SKIN CANCER ( 1 patients )
DIFFUSE VASCULITIS ( 1 patients )
NEPHRITIC SYNDROME ( 1 patients )
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY ( 1 patients )
SKIN LESION ( 1 patients )
VASCULAR OPERATION ( 1 patients )
CONGENITAL NEPHROTIC SYNDROME ( 1 patients )
HEPATIC NECROSIS ( 1 patients )
ERYTHEMA MULTIFORME ( 1 patients )
NEUROPATHY ( 1 patients )
RENAL FAILURE CHRONIC ( 1 patients )
CONJUNCTIVOPLASTY ( 1 patients )
MIXED CONNECTIVE TISSUE DISEASE ( 1 patients )
SYMPATHETIC OPHTHALMIA ( 1 patients )
BASAL CELL CARCINOMA ( 1 patients )
OCULAR HYPERTENSION ( 1 patients )
HERPES OPHTHALMIC ( 1 patients )
SYSTEMIC LUPUS ERYTHEMATOSUS RASH ( 1 patients )
HYPOVOLAEMIA ( 1 patients )
TAKAYASU'S ARTERITIS ( 1 patients )
BONE MARROW CONDITIONING REGIMEN ( 1 patients )
PANNICULITIS ( 1 patients )
SARCOIDOSIS ( 1 patients )
ALVEOLITIS ( 1 patients )
LINEAR IGA DISEASE ( 1 patients )
IMMUNOGLOBULINS INCREASED ( 1 patients )
TUBULOINTERSTITIAL NEPHRITIS AND UVEITIS SYNDROME ( 1 patients )
CHOROIDITIS ( 1 patients )
POLYARTHRITIS ( 1 patients )
NEOPLASM MALIGNANT ( 1 patients )
RASH MACULO-PAPULAR ( 1 patients )
URINARY SEDIMENT PRESENT ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with DIZZINESS:

ASPIRIN (11600 patients)
VIOXX (7378 patients)
LYRICA (6860 patients)
FOSAMAX (5996 patients)
FORTEO (5954 patients)
LIPITOR (5176 patients)
LISINOPRIL (4887 patients)
SYNTHROID (4476 patients)
SEROQUEL (4354 patients)
HEPARIN SODIUM INJECTION (3939 patients)
PAXIL (3927 patients)
NEXIUM (3724 patients)
ATENOLOL (3642 patients)
CYMBALTA (3597 patients)
DIGOXIN (3592 patients)
LASIX (3474 patients)
SIMVASTATIN (3462 patients)
BYETTA (3410 patients)
PLAVIX (3379 patients)
HUMIRA (3370 patients)
NEURONTIN (3252 patients)
PREDNISONE (3235 patients)
ENBREL (3099 patients)
COUMADIN (3094 patients)
CHANTIX (3093 patients)
XANAX (3083 patients)
HYDROCHLOROTHIAZIDE (3080 patients)
FUROSEMIDE (3079 patients)
NORVASC (2961 patients)
TYSABRI (2952 patients)
ZOLOFT (2880 patients)
OMEPRAZOLE (2836 patients)
DIOVAN (2690 patients)
TOPROL-XL (2659 patients)
METFORMIN HCL (2632 patients)
ZOCOR (2483 patients)
ZOMETA (2466 patients)
LEVOTHYROXINE SODIUM (2438 patients)
FOLIC ACID (2398 patients)
AMBIEN (2378 patients)
PRILOSEC (2373 patients)
CRESTOR (2338 patients)
ALBUTEROL (2309 patients)
CELEBREX (2296 patients)
VITAMIN D (2246 patients)
REMICADE (2244 patients)
AVONEX (2214 patients)
LEXAPRO (2189 patients)
METHOTREXATE (2180 patients)
PROTONIX (2174 patients)
IBUPROFEN (2089 patients)
PREVACID (2079 patients)
LANTUS (2049 patients)
CALCIUM (1959 patients)
GABAPENTIN (1926 patients)
LORAZEPAM (1915 patients)
COREG (1895 patients)
NIASPAN (1888 patients)
EFFEXOR XR (1866 patients)
METOPROLOL TARTRATE (1858 patients)
ACETAMINOPHEN (1845 patients)
ADVAIR DISKUS 100/50 (1837 patients)
WARFARIN SODIUM (1821 patients)
CLONAZEPAM (1782 patients)
VICODIN (1736 patients)
POTASSIUM CHLORIDE (1714 patients)
ALLOPURINOL (1636 patients)
LEVAQUIN (1611 patients)
ATIVAN (1604 patients)
EFFEXOR (1595 patients)
PREMARIN (1591 patients)
NAMENDA (1587 patients)
SANDOSTATIN LAR (1547 patients)
LAMICTAL (1533 patients)
WELLBUTRIN (1519 patients)
KLONOPIN (1515 patients)
AMLODIPINE (1514 patients)
FLOMAX (1503 patients)
AVELOX (1487 patients)
OXYCONTIN (1484 patients)
MULTI-VITAMIN (1465 patients)
DIAZEPAM (1453 patients)
PROZAC (1448 patients)
SINGULAIR (1440 patients)
PERCOCET (1426 patients)
PRISTIQ (1425 patients)
PRADAXA (1392 patients)
SPIRIVA (1390 patients)
DURAGESIC-100 (1342 patients)
METOPROLOL (1339 patients)
AREDIA (1332 patients)
INSULIN (1328 patients)
ALPRAZOLAM (1307 patients)
MULTI-VITAMINS (1298 patients)
NITROGLYCERIN (1284 patients)
GLUCOPHAGE (1271 patients)
AVANDIA (1257 patients)
VALIUM (1245 patients)
COZAAR (1231 patients)
ZETIA (1224 patients)
RIBAVIRIN (1219 patients)
ZYRTEC (1201 patients)
CELEXA (1195 patients)
ACTOS (1180 patients)
PREDNISONE TAB (1157 patients)
TRAMADOL HCL (1152 patients)
ZYPREXA (1121 patients)
DEXAMETHASONE (1117 patients)
ZANTAC (1114 patients)
FISH OIL (1113 patients)
ALLEGRA (1113 patients)
SPIRONOLACTONE (1112 patients)
GLIPIZIDE (1110 patients)
BENADRYL (1109 patients)
TOPAMAX (1096 patients)
TEGRETOL (1089 patients)
ACCUTANE (1088 patients)
GILENYA (1086 patients)
GLYBURIDE (1086 patients)
TRAZODONE HCL (1086 patients)
METFORMIN (1076 patients)
RISPERDAL (1076 patients)
PAROXETINE HCL (1070 patients)
PEGASYS (1053 patients)
VITAMIN B-12 (1042 patients)
OXYCODONE HCL (1028 patients)
LORTAB (1026 patients)
CITALOPRAM HYDROBROMIDE (1026 patients)
CARVEDILOL (1021 patients)
VALTREX (1021 patients)
VITAMIN E (1021 patients)
ZOFRAN (1019 patients)
MORPHINE (1019 patients)
REBIF (1018 patients)
ALTACE (999 patients)
LEVOXYL (995 patients)
TYLENOL (990 patients)
MIRENA (987 patients)
REVLIMID (974 patients)
TYLENOL (CAPLET) (965 patients)
FLEXERIL (962 patients)
HUMALOG (956 patients)
ASCORBIC ACID (955 patients)
PREDNISOLONE (953 patients)
AMITRIPTYLINE HCL (953 patients)
CLOZARIL (943 patients)
RAMIPRIL (929 patients)
ENALAPRIL MALEATE (927 patients)
CLONIDINE (926 patients)
RANITIDINE (904 patients)
AMOXICILLIN (896 patients)
BACLOFEN (895 patients)
YASMIN (863 patients)
AMARYL (853 patients)
DEPAKOTE (839 patients)
LOPRESSOR (838 patients)
FLONASE (836 patients)
ACTONEL (829 patients)
CLARITIN (821 patients)
METOPROLOL SUCCINATE (821 patients)
LANSOPRAZOLE (818 patients)
CALCIUM CARBONATE (813 patients)
ABILIFY (809 patients)
YAZ (808 patients)
ACIPHEX (798 patients)
VERAPAMIL (793 patients)
DECADRON (791 patients)
FENTANYL (789 patients)
STRATTERA (779 patients)
NAPROXEN (773 patients)
PEG-INTRON (764 patients)
EXJADE (761 patients)
TRICOR (761 patients)
ACETYLSALICYLIC ACID SRT (754 patients)
KEPPRA (752 patients)
BENICAR (747 patients)
BONIVA (746 patients)
DILANTIN (744 patients)
DIOVAN HCT (739 patients)
VYTORIN (736 patients)
ALEVE (736 patients)
TRILEPTAL (736 patients)
MECLIZINE (736 patients)
REGLAN (733 patients)
TRACLEER (731 patients)
CARDIZEM (730 patients)
NICODERM CQ (724 patients)
BETASERON (720 patients)
HEPARIN SODIUM (719 patients)
TEMAZEPAM (719 patients)
ULTRAM (716 patients)
ZELNORM (715 patients)
ALENDRONATE SODIUM (702 patients)
PRAVACHOL (700 patients)
VITAMINS (695 patients)
ALDACTONE (692 patients)
POTASSIUM (692 patients)
CIPROFLOXACIN (679 patients)
DILTIAZEM (678 patients)
IRON (675 patients)
MIRTAZAPINE (674 patients)
HYDROCODONE (674 patients)
COMPAZINE (673 patients)
PRAVASTATIN (670 patients)
SOLIRIS (669 patients)
PEPCID (657 patients)
MULTIVITAMIN (656 patients)
PROMETHAZINE (656 patients)
AMLODIPINE BESYLATE (656 patients)
ZITHROMAX (656 patients)
Most common side effects for patients taking MYCOPHENOLATE MOFETIL:
CYTOMEGALOVIRUS INFECTION (1602 patients)
PYREXIA (1360 patients)
DIARRHOEA (1252 patients)
BLOOD CREATININE INCREASED (1053 patients)
PNEUMONIA (991 patients)
TRANSPLANT REJECTION (865 patients)
SEPSIS (848 patients)
URINARY TRACT INFECTION (812 patients)
KIDNEY TRANSPLANT REJECTION (800 patients)
RENAL IMPAIRMENT (751 patients)
ANAEMIA (720 patients)
RENAL FAILURE ACUTE (568 patients)
LEUKOPENIA (557 patients)
RENAL FAILURE (544 patients)
VOMITING (535 patients)
NAUSEA (500 patients)
DEATH (493 patients)
MULTI-ORGAN FAILURE (471 patients)
ABDOMINAL PAIN (465 patients)
PLEURAL EFFUSION (446 patients)
DEHYDRATION (432 patients)
DRUG INEFFECTIVE (426 patients)
LYMPHOCELE (416 patients)
PANCYTOPENIA (408 patients)
COMPLICATIONS OF TRANSPLANTED KIDNEY (405 patients)
RESPIRATORY FAILURE (404 patients)
HYPERTENSION (402 patients)
HAEMOGLOBIN DECREASED (391 patients)
INFECTION (376 patients)
HAEMODIALYSIS (370 patients)
DRUG INTERACTION (360 patients)
THROMBOCYTOPENIA (356 patients)
HYPOTENSION (346 patients)
GRAFT VERSUS HOST DISEASE (322 patients)
DYSPNOEA (321 patients)
GASTROINTESTINAL HAEMORRHAGE (313 patients)
ENTEROCOCCAL INFECTION (299 patients)
CYTOMEGALOVIRUS VIRAEMIA (294 patients)
THROMBOTIC MICROANGIOPATHY (290 patients)
HERPES ZOSTER (284 patients)
STAPHYLOCOCCAL INFECTION (284 patients)
OEDEMA PERIPHERAL (283 patients)
HAEMATOMA (280 patients)
LIVER TRANSPLANT REJECTION (272 patients)
DIABETES MELLITUS (272 patients)
NEUTROPENIA (269 patients)
ASTHENIA (268 patients)
SEPTIC SHOCK (266 patients)
ESCHERICHIA INFECTION (262 patients)
WHITE BLOOD CELL COUNT DECREASED (258 patients)
ASCITES (256 patients)
ACUTE GRAFT VERSUS HOST DISEASE (251 patients)
HEADACHE (246 patients)
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER (246 patients)
PYELONEPHRITIS (245 patients)
DISEASE RECURRENCE (239 patients)
NEPHROPATHY TOXIC (237 patients)
PROTEINURIA (227 patients)
WEIGHT DECREASED (220 patients)
COUGH (219 patients)
BLOOD BILIRUBIN INCREASED (219 patients)
CELLULITIS (213 patients)
TREMOR (211 patients)
CONVULSION (210 patients)
ASPERGILLOSIS (209 patients)
PERITONITIS (209 patients)
DRUG TOXICITY (207 patients)
GRAFT DYSFUNCTION (204 patients)
PSEUDOMONAS INFECTION (203 patients)
UROSEPSIS (203 patients)
CARDIAC ARREST (201 patients)
OEDEMA (200 patients)
CARDIAC FAILURE (193 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (191 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN (188 patients)
GASTROENTERITIS (187 patients)
HAEMATURIA (186 patients)
CANDIDIASIS (186 patients)
MYOCARDIAL INFARCTION (184 patients)
MALAISE (183 patients)
ALANINE AMINOTRANSFERASE INCREASED (182 patients)
CHRONIC ALLOGRAFT NEPHROPATHY (182 patients)
CHOLESTASIS (180 patients)
BACK PAIN (178 patients)
LYMPHOPROLIFERATIVE DISORDER (176 patients)
BACTERIAL INFECTION (175 patients)
ATRIAL FIBRILLATION (169 patients)
RENAL TUBULAR NECROSIS (169 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (168 patients)
BRONCHOPULMONARY ASPERGILLOSIS (167 patients)
HYPERKALAEMIA (166 patients)
PLATELET COUNT DECREASED (164 patients)
POST PROCEDURAL COMPLICATION (164 patients)
ABDOMINAL PAIN UPPER (162 patients)
LUNG INFILTRATION (161 patients)
AGRANULOCYTOSIS (161 patients)
APLASIA PURE RED CELL (160 patients)
EPSTEIN-BARR VIRUS INFECTION (160 patients)
PAIN (160 patients)
METABOLIC ACIDOSIS (158 patients)
PULMONARY OEDEMA (157 patients)
FEBRILE NEUTROPENIA (157 patients)
CHRONIC GRAFT VERSUS HOST DISEASE (155 patients)
DECREASED APPETITE (155 patients)
CONDITION AGGRAVATED (152 patients)
HEPATIC ENZYME INCREASED (151 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (150 patients)
HEPATIC FAILURE (148 patients)
FUNGAL INFECTION (147 patients)
BACTERAEMIA (147 patients)
HEPATITIS C (147 patients)
FATIGUE (147 patients)
BLOOD LACTATE DEHYDROGENASE INCREASED (147 patients)
BK VIRUS INFECTION (146 patients)
LIVER FUNCTION TEST ABNORMAL (145 patients)
HYPERGLYCAEMIA (145 patients)
HEART TRANSPLANT REJECTION (144 patients)
BONE MARROW FAILURE (144 patients)
INTERSTITIAL LUNG DISEASE (143 patients)
HEPATIC FUNCTION ABNORMAL (141 patients)
RASH (140 patients)
LYMPHADENOPATHY (139 patients)
CHOLANGITIS (139 patients)
BLOOD ALBUMIN DECREASED (139 patients)
C-REACTIVE PROTEIN INCREASED (138 patients)
DEEP VEIN THROMBOSIS (137 patients)
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY (136 patients)
HYDRONEPHROSIS (132 patients)
WOUND INFECTION (132 patients)
HYPERBILIRUBINAEMIA (132 patients)
TRANSPLANT FAILURE (131 patients)
WHITE BLOOD CELL COUNT INCREASED (130 patients)
CHILLS (128 patients)
OXYGEN SATURATION DECREASED (128 patients)
ARTHRALGIA (127 patients)
PAIN IN EXTREMITY (127 patients)
WOUND SECRETION (126 patients)
DIZZINESS (125 patients)
FALL (124 patients)
IMPAIRED HEALING (123 patients)
TRANSAMINASES INCREASED (122 patients)
URETERIC STENOSIS (122 patients)
HAEMORRHAGE (121 patients)
CONFUSIONAL STATE (121 patients)
BILE DUCT STENOSIS (121 patients)
KLEBSIELLA INFECTION (121 patients)
URINE OUTPUT DECREASED (120 patients)
PULMONARY EMBOLISM (119 patients)
POST PROCEDURAL BILE LEAK (119 patients)
WOUND DEHISCENCE (118 patients)
CHEST PAIN (117 patients)
CARDIAC FAILURE CONGESTIVE (117 patients)
OLIGURIA (116 patients)
POST PROCEDURAL HAEMORRHAGE (115 patients)
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED (115 patients)
HYPERLIPIDAEMIA (115 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE (114 patients)
GASTROENTERITIS VIRAL (111 patients)
WEIGHT INCREASED (111 patients)
CHOLECYSTITIS ACUTE (109 patients)
PNEUMATOSIS INTESTINALIS (109 patients)
PYELONEPHRITIS ACUTE (109 patients)
RESPIRATORY DISTRESS (108 patients)
TACHYCARDIA (106 patients)
GASTROINTESTINAL DISORDER (106 patients)
OSTEONECROSIS (106 patients)
HYPOXIA (105 patients)
KAPOSI'S SARCOMA (105 patients)
ASCITES INFECTION (104 patients)
MYOPATHY (103 patients)
GASTRITIS (103 patients)
MUCOSAL INFLAMMATION (103 patients)
COMPLICATIONS OF TRANSPLANTED LIVER (103 patients)
CONSTIPATION (102 patients)
BLOOD CULTURE POSITIVE (102 patients)
RHABDOMYOLYSIS (102 patients)
BRONCHIECTASIS (102 patients)
RENAL ARTERY STENOSIS (101 patients)
GASTRIC ULCER (101 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (101 patients)
SYSTEMIC LUPUS ERYTHEMATOSUS (101 patients)
LUNG INFECTION (100 patients)
LOSS OF CONSCIOUSNESS (99 patients)
DIALYSIS (99 patients)
CEREBROVASCULAR ACCIDENT (99 patients)
LUNG DISORDER (98 patients)
MUSCULAR WEAKNESS (98 patients)
LIVER DISORDER (97 patients)
HEPATOTOXICITY (97 patients)
HYPONATRAEMIA (97 patients)
THROMBOSIS (96 patients)
SURGERY (95 patients)
RENAL TUBULAR DISORDER (95 patients)
SKIN LESION (94 patients)
VIRAL INFECTION (94 patients)
CYTOMEGALOVIRUS ANTIGEN POSITIVE (94 patients)
ANOREXIA (93 patients)
HYPOGAMMAGLOBULINAEMIA (93 patients)
DRUG LEVEL INCREASED (92 patients)
CALCULUS URETERIC (92 patients)
RENAL TRANSPLANT (92 patients)
NEUTROPHIL PELGER-HUET ANOMALY PRESENT (91 patients)
HYPERCHOLESTEROLAEMIA (91 patients)
RENAL FAILURE CHRONIC (91 patients)
HYPERTRIGLYCERIDAEMIA (90 patients)
ENCEPHALOPATHY (90 patients)
PULMONARY HYPERTENSION (90 patients)
ANURIA (90 patients)
LACERATION (89 patients)
PNEUMOCYSTIS JIROVECI PNEUMONIA (89 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for MYCOPHENOLATE MOFETIL


Issue Description / Topic Timestamp
QUESTION
SUDDEN HEARING LOSS
Is there any effect of mycophenolate mofetil on hearing? Does it cause sudden onset hearing loss? 2015-05-23 08:38:12
QUESTION
NIGHTMARE
does mycophenolate cause nightmares? 2015-09-18 21:23:21
QUESTION
MOBILITY DECREASED
My husband has Parkisons-like Symptoms. Could the fact that he takes Cellcept for a kidney transplant aggravate the the tremors and mobility problems? 2016-01-07 21:13:23
QUESTION
BRONCHITIS
Is bronchitis a common side effect of CellCept? 2016-03-22 13:59:10
QUESTION
DRUG INTERACTION
CAn mycophenolate interact with epilim 2016-07-07 01:06:33
QUESTION
PALPITATIONS
PALPITATIONS and MYCOPHENOLATE MOFETIL (CELLCEPT) are they connected 2016-08-24 18:10:49
QUESTION
GINGIVAL HYPERPLASIA
Does MYCOPHENOLATE MOFETIL cause gingival[gum] hyperplasia[overgrowth]? 2016-10-25 20:38:25
QUESTION
DELUSION
My uncle has taken this drug for 3+ months. He is experiencing delusions. Is this a possible side effect of this drug? 2017-01-17 19:08:32
QUESTION
DERMAL CYST
Does mycophenolate cause hearing loss? 2017-03-16 23:34:26
QUESTION
ABDOMINAL PAIN
You can definitely see your expertise in the article you write.The arena hopes for more passionate writers like you who aren7#821&;t afraid to say how they believe. At all times go after your heart. 2017-03-20 09:02:00
QUESTION
OSTEONECROSIS
Can Osteonecrosis be a side effect from taking Mycophenolate? 2017-04-11 16:47:49
QUESTION
DEMENTIA
does mycophenolate cause dementia 2017-05-16 18:57:33
QUESTION
TRANSIENT ISCHAEMIC ATTACK
I am taking cellcept. I have had transient ischemic attacks. Did cellcept cause them? I have also lost my sense of taste and smell. 2017-06-26 18:15:18

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about DIZZINESS and MYCOPHENOLATE MOFETIL, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking MYCOPHENOLATE MOFETIL, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in MYCOPHENOLATE MOFETIL. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for MYCOPHENOLATE MOFETIL experts. If you are a healthcare provider experienced in prescribing MYCOPHENOLATE MOFETIL, please register here.

Your online appointment book for Winfield Rentals & Services

© 2014 FactMed, Inc
Privacy Policy
Terms of Use